Press Releases

Press Releases

09.22.15
OpGen to Present Data Showing Acuitas(R) Tests are Effective Tools for Investigating Transmission of "Super Bugs"
08.13.15
OpGen Reports Second Quarter Financial Results and Provides Business Update
08.05.15
OpGen, Inc. Announces Timing for Second Quarter Financial Results and Conference Call
07.14.15
OpGen Closes $6 Million Financing With Merck GHI to Expand Infectious Disease Diagnostic Testing Capabilities
07.14.15
OpGen to Acquire AdvanDx, Inc.
07.13.15
Fluidigm and OpGen Enter Into Strategic Agreement to Develop Multi-Drug Resistance Testing Kits and Equipment
06.17.15
OpGen Reports First Quarter Financial Results and Provides Business Update
06.11.15
OpGen, Inc. Announces Timing for First Quarter Financial Results and Conference Call
06.02.15
OpGen Releases Next-Generation Molecular Testing and Bioinformatics Solution for Combating Multi-Drug Resistant Infections
05.27.15
OpGen's Acuitas(R) MDRO Gene Tests and Bioinformatics Data to be Presented at ASM2015